Celltex Therapeutics Corporation Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Therapy Services
  • Stem Cell Banking
  • The Celltex Difference
  • How It Works
  • Our Science & Lab
  • View Clinical Trials
  • Conditions, Disorders & Diseases
  • Frequently Asked Questions
  • News & Press
  • Client Results
  • Client Stories
  • Client Assessment
  • Attend a Webinar
  • View our Online Webinar
  • View More

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.

Celltex Therapeutics Corporation Logo Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us
  • Products & Services
    • Therapy
    • Stem Cell Banking
    • The Celltex Difference
  • How It Works
    • How It Works
    • Our Science & Lab
    • Conditions, Disorders & Diseases
  • Results
    • Clinical Trials
    • Client Results
    • Client Stories
  • Resources
    • Stem Cell 101
    • Attend a Webinar
    • View Previous Webinars
    • Request Information
    • Client Assessment
    • Extraction Sites
    • For Physicians
    • Company Information
    • Careers
  • FAQs
  • News

Celltex News

U.S. Congressman John Culberson visits Celltex lab

Posted on Jul 5th, 2018

Celltex proudly welcomed U.S. Congressman John Culberson, representative of the 7th District of Texas, to its offices in Houston, Texas. Celltex executive team members met with Culberson and presented him with Celltex updates and news, including partnerships for clinical research trials with Texas A&M Institute for Regenerative Medicine and Comisión Federal Para La Protección Contra Riesgos Sanitarios Comisión de Autorización Sanitaria (COFEPRIS), Mexico’s equivalent governmental regulatory body to the United States Food and Drug Administration (FDA).

Rep. Culberson also received a tour of Celltex’s state-of-the-art laboratory to observe how adult stem cells are processed in the lab, which is compliant with current Good Manufacturing Practice (cGMP) standards as recommended by the FDA for the manufacturing of biological products. He learned more about Celltex’s safety protocols and the safety testing that takes place each day to ensure the integrity of a client’s stem cells.

Celltex looks forward to working with Rep. Culberson on bringing stem cell therapy to the United States, in hopes that one day, millions of Americans in need will be able to access the regenerative power of their own adult stem cells for therapeutic purposes.


From left to right: David Eller, Celltex CEO, Chairman and Co-Founder; Congressman John Culberson; Dr. Jane Young, Celltex Chief Scientific Officer; Aditi Kaushik, Celltex Manufacturing Manager; Erik Eller, Celltex Vice President, Operations

Post Tags: business development, press release, stem cell therapy


More Recent News

Exploring Regenerative Medicine Beyond Stem Cell Therapy

For many, stem cell therapy is to regenerative medicine what Google is to internet searches. Yet, there are other procedures within the regenerative medicine field that may be recommended depending on the health concern being addressed.

In this article, we explore several regenerative medicine options, including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), stromal vascular fraction (SVF), and exosomes.

Read More

What Makes MSCs So Promising? A Deep Dive on Mesenchymal Stem Cells

Present in the body throughout one’s lifespan, adult Mesenchymal Stem Cells (MSCs) can be used in many types of regenerative medicine. This article explores how MSCs work in the body and what makes them suitable for therapeutic application.

Read More

Post Types

  • Press Releases & Company Updates
  • Celltex in the News
  • Blog Posts & Client Stories

Topics

adult stem cell therapy alzheimer Andrews Celltex Biologics Andrews Medicine arthritis autoimmune condition Biologic License biotech companies brain disease business development celebrities celltex team chronic illness client testimonial clinical research clinical trial david eller FDA fight for stem cell therapy innovation in the news Investigational New Drug medical research miracle story MS MS research multiple sclerosis news reference Orthopedics pain relief Parkinson's disease president trump press release Regenerative Medicine Research saudi arabia Sports Injury Program Sports Medicine stem cell banking stem cell therapy stem cell therapy for alzheimers stem cell therapy in texas stem cell treatment success stories systemic juvenile idiopathic arthritis

Media Contacts

For media inquiries, please contact Lisa Spence at 713-552-1055.

Celltex Logo
  • ESPAÑOL
  • Enroll Today
  • Request Information
  • Contact Us

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Vimeo

About

  • Company Information
  • About Celltex
  • Board of Directors
  • Executive Team
  • Client Services Team
  • Celltex Mexico
  • Site Map
  • News & Press
  • Careers

Partners

  • Medical Professionals

Legal

  • Privacy Policy
  • Terms & Conditions

© 2025 Celltex Therapeutics Corporation. All rights reserved.